FIELD: biotechnology.
SUBSTANCE: group of inventions is described that contains a pharmaceutical composition of doxorubicin included in phospholipid nanoparticles with AS1411 aptamer in the form of a conjugate with DSPE-PEG2000-Mal, for targeted delivery of a cytostatic agent to a tumor, and a method for producing the composition. In one of the embodiments of the invention, the pharmaceutical composition contains phospholipids, doxorubin and AS1411 aptamer conjugate with DSPE-PEG2000 -Mal.
EFFECT: invention expands the arsenal of means for targeted delivery of a cytostatic agent to a tumor.
2 cl, 4 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING CHLORIN E6 IN PHOSPHOLIPID NANOPARTICLES USING SPECIFIC AND PENETRATING PEPTIDES AS TARGETED MOLECULES FOR TARGETED TRANSPORT | 2020 |
|
RU2747485C1 |
ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
COMBINATION LIPOSOMAL COMPOSITIONS FOR CANCER TREATMENT | 2012 |
|
RU2640934C2 |
LIPID NANOPARTICLES FOR IN VIVO MEDICINAL PRODUCTS DELIVERY AND THEIR USE | 2020 |
|
RU2799045C1 |
PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
HIGHLY EFFECTIVE METHOD FOR PREPARING DOSAGE FORM OF TARGETED ACTION FOR THERAPY OF MALIGNANT GROWTHS | 2019 |
|
RU2727924C1 |
CONJUGATE OF ANTITUMOUR DRUGS WITH RECOMBINANT ALPHA-FETOPROTEIN AND ITS FUNCTIONAL FRAGMENTS AND METHOD OF THEIR PRODUCING | 2016 |
|
RU2630974C1 |
NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF | 2012 |
|
RU2599449C1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS | 2019 |
|
RU2710273C1 |
Authors
Dates
2023-04-25—Published
2021-11-22—Filed